Citius Oncology Inc (CTOR)

Finanzdaten der Citius Oncology Inc-Aktie (CTOR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.41%1.49	1.67	3.94	-	-
Cost Of Revenue	49.55%0.49	0.33	0.79	-	-
Gross Profit	25.14%1.00	1.34	3.15	-	-
	67.55%9.72	29.95	8.41	4.71	4.94
Research and Development	79.76%0.22	1.08	1.02	1.08	0.94
Operating Income/Loss	69.54%-8.72	-28.61	-5.25	-4.71	-4.94
Nonoperating Income/Loss	117.73%-0.31	1.77	-0.02	-	-
Income/Loss From Continuing Operations Before Tax	66.35%-9.03	-26.84	-5.27	-4.73	-5.11
Income Tax Expense/Benefit, Deferred	53.57%-0.11	-0.23	0.26	0.26	0.26
Income Tax Expense/Benefit	53.57%-0.11	-0.23	0.26	0.26	0.26
	66.46%-8.92	-26.61	-5.53	-5.00	-5.37
Attributable To Parent	66.46%-8.92	-26.61	-5.53	-5.00	-5.37
Basic Average Shares	7.86%107.89	100.03	87.46	1.72	71.55
Diluted Average Shares	7.86%107.89	100.03	87.46	1.72	71.55
Basic Earnings Per Share	70.37%-0.08	-0.27	-0.06	-0.06	-0.08
Diluted Earnings Per Share	70.37%-0.08	-0.27	-0.06	-0.06	-0.08